Minimal Physiologically Based Pharmacokinetic Model of Intravenously and Orally Administered Delta-9-Tetrahydrocannabinol in Healthy Volunteers

被引：0
|
作者：
William R. Wolowich
Robert Greif
Maren Kleine-Brueggeney
Werner Bernhard
Lorenz Theiler
机构：
[1] Nova Southeastern University,College of Pharmacy
[2] University of Bern,University Department of Anesthesiology and Pain Therapy, Inselspital, Bern University Hospital
[3] Guy’s and St. Thomas NHS Foundation Trust,Department of Anesthesia, Evelina London Children’s Hospital
[4] University of Bern,Institute of Forensic Medicine
来源：
European Journal of Drug Metabolism and Pharmacokinetics | 2019年 / 44卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：691 / 711
页数：20
相关论文
共 50 条
  • [1] Minimal Physiologically Based Pharmacokinetic Model of Intravenously and Orally Administered Delta-9-Tetrahydrocannabinol in Healthy Volunteers
    Wolowich, William R.
    Greif, Robert
    Kleine-Brueggeney, Maren
    Bernhard, Werner
    Theiler, Lorenz
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2019, 44 (05) : 691 - 711
  • [2] EFFECTS OF ORALLY ADMINISTERED DELTA-9-TETRAHYDROCANNABINOL IN MAN
    HOSKO, MJ
    KOCHAR, MS
    WANG, RIH
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1973, 14 (03) : 344 - 352
  • [3] Physiologically Based Pharmacokinetic Modeling of Cannabidiol, Delta-9-Tetrahydrocannabinol, and Their Metabolites in Healthy Adults After Administration by Multiple Routes
    Qian, Lixuan
    Zhang, Tao
    Dinh, Jean
    Paine, Mary F.
    Zhou, Zhu
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2025, 18 (01):
  • [4] Acute effects of delta-9-tetrahydrocannabinol on performance monitoring in healthy volunteers
    Spronk, Desiree
    Dumont, Glenn J. H.
    Verkes, Robbert J.
    de Bruijn, Ellen R. A.
    FRONTIERS IN BEHAVIORAL NEUROSCIENCE, 2011, 5
  • [5] COMPARISON OF PHARMACOLOGICAL ACTIVITY IN MAN OF INTRAVENOUSLY ADMINISTERED DELTA-9-TETRAHYDROCANNABINOL, CANNABINOL, AND CANNABIDIOL
    PEREZREYES, M
    TIMMONS, MC
    DAVIS, KH
    WALL, EM
    EXPERIENTIA, 1973, 29 (11): : 1368 - 1369
  • [6] DELTA-9-TETRAHYDROCANNABINOL ADMINISTERED TO PREGNANT RATS
    UYENO, ET
    PHARMACOLOGIST, 1975, 17 (02): : 181 - 181
  • [7] PHARMACOLOGY OF ORALLY ADMINISTERED DELTA(9)-TETRAHYDROCANNABINOL
    PEREZREY.M
    LIPTON, MA
    TIMMONS, MC
    WALL, ME
    BRINE, DR
    DAVIS, KH
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1973, 14 (01) : 48 - 55
  • [8] THE EFFECT OF CHRONICALLY ADMINISTERED DELTA-9-TETRAHYDROCANNABINOL UPON THE POLYGRAPHICALLY MONITORED SLEEP OF NORMAL VOLUNTEERS
    FREEMON, FR
    DRUG AND ALCOHOL DEPENDENCE, 1982, 10 (04) : 345 - 353
  • [9] Population pharmacokinetic model of delta-9-tetrahydrocannabinol (THC) in cannabis occasional smokers
    Marsot, A.
    Audebert, C.
    Attolini, L.
    Micallef, J.
    Blin, O.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2016, 30 : 16 - 17
  • [10] Development of Physiologically Based Pharmacokinetic Model for Orally Administered Fexuprazan in Humans
    Jeong, Yoo-Seong
    Kim, Min-Soo
    Lee, Nora
    Lee, Areum
    Chae, Yoon-Jee
    Chung, Suk-Jae
    Lee, Kyeong-Ryoon
    PHARMACEUTICS, 2021, 13 (06)
12345